Clinical Trials Browser

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioma, Medulloblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

NCT03015922 2020-01-22

MUKeleven

Phase 1 Unknown

4 enrolled

Plasma cell

Multiple Myeloma

NCT01274624 2018-12-19

Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer

Phase 1 Completed

36 enrolled

Tumor-Agnostic

Neoplasms

NCT02620423 2018-09-13

Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma

Phase 1 Completed

11 enrolled

Tumor-Agnostic

Neoplasms

NCT02723838 2017-03-07

Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder

Phase 1 Withdrawn

Tumor-Agnostic

Neoplasms

NCT00602277 2016-08-08

Viral Therapy in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Did Not Respond to Platinum Chemotherapy

Phase 1 Completed

70 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01533194 2015-04-15

Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1 Completed

12 enrolled

Plasma cell

Multiple Myeloma

NCT00528684 2014-10-02

Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas

Phase 1 Completed

18 enrolled

CNS

Glioblastoma, Glioma

NCT01240538 2014-05-13

Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors

Phase 1 Completed

26 enrolled

Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific